article thumbnail

5 Best Healthcare Stocks to Buy in 2023

Savings Corner

The company is also developing drugs targeting other rare genetic diseases, as well as more common diseases, including type 1 diabetes. The COVID-19 pandemic hurt the company’s business since many elective surgeries were postponed. It also operates one of the biggest PBMs and is a leader in healthcare delivery services.